EUVIMEDEUVIMED entdecken
Leserbrief

The Pathophysiological and Therapeutic Implications of Cardiac Light-Chain Amyloidosis Compared With Transthyretin Amyloidosis

Joel D Schilling, Mario Nuvolone, Giampaolo Merlini

JACC: Heart Failure · 2024

DOI: 10.1016/j.jchf.2024.07.003 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JACC: Heart Failure, 2024. Verfasst von Joel D Schilling und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Medicine, Washington University…. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Ministry of Health, Cariplo Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialHumansCardiomyopathiesHeart FailureImmunoglobulin Light-chain Amyloidosis

Stichwörter der Autor:innen

cardiac amyloidosislight chain amyloidosismitochondria damage transthyretin amyloidosis

Autor:innen und Institutionen

  • Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Pathology…
  • Department of Molecular Medicine, University of Pavia, Pavia, Italy; Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Department of Molecular Medicine, University of Pavia, Pavia, Italy; Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address: giampaolo.merlini@unipv.it.

Förderung

  • Ministry of Health
  • Cariplo Foundation

Zitieren

APA

Schilling, J. D., Nuvolone, M., & Merlini, G. (2024). The Pathophysiological and Therapeutic Implications of Cardiac Light-Chain Amyloidosis Compared With Transthyretin Amyloidosis. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2024.07.003

Vancouver

Schilling JD, Nuvolone M, Merlini G. The Pathophysiological and Therapeutic Implications of Cardiac Light-Chain Amyloidosis Compared With Transthyretin Amyloidosis. JACC: Heart Failure. 2024. doi:10.1016/j.jchf.2024.07.003

BibTeX
@article{Schilling2024,
  author = {Schilling, Joel D and Nuvolone, Mario and Merlini, Giampaolo},
  title = {The Pathophysiological and Therapeutic Implications of Cardiac Light-Chain Amyloidosis Compared With Transthyretin Amyloidosis},
  journal = {JACC: Heart Failure},
  year = {2024},
  doi = {10.1016/j.jchf.2024.07.003}
}
Kostenlos starten →